IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Financials Imeik Technology Development Co.,Ltd.
Equities
300896
CNE100004868
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 297 CNY | +1.31% |
|
+6.26% | +0.91% |
| Apr. 24 | Imeik Technology Development Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 20 | Imeik Technology Development's Profit Rises 47% on Higher Revenue | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 78,733 | 115,993 | 122,535 | 63,540 | 63,915 | - | - |
| Enterprise Value (EV) 1 | 78,733 | 112,737 | 119,407 | 61,121 | 59,882 | 57,893 | 55,388 |
| P/E ratio | 145 x | 121 x | 97 x | 34.2 x | 26.1 x | 19.9 x | 16.2 x |
| Yield | 0.53% | 0.39% | 0.49% | 0.79% | 1.55% | 1.91% | 2.28% |
| Capitalization / Revenue | 111 x | 80.1 x | 63.2 x | 22.1 x | 16.4 x | 12.4 x | 9.98 x |
| EV / Revenue | 111 x | 77.9 x | 61.6 x | 21.3 x | 15.4 x | 11.2 x | 8.65 x |
| EV / EBITDA | 153 x | 99.1 x | 79.4 x | 27.8 x | 21.2 x | 15.8 x | 12.3 x |
| EV / FCF | - | 123 x | 115 x | 32.3 x | 22.5 x | 19.2 x | 15.1 x |
| FCF Yield | - | 0.82% | 0.87% | 3.09% | 4.45% | 5.22% | 6.63% |
| Price to Book | 17.4 x | 23.1 x | 21 x | 10 x | 7.94 x | 5.89 x | 4.61 x |
| Nbr of stocks (in thousands) | 216,360 | 216,360 | 216,360 | 215,880 | 215,194 | - | - |
| Reference price 2 | 363.9 | 536.1 | 566.4 | 294.3 | 297.0 | 297.0 | 297.0 |
| Announcement Date | 2/8/21 | 3/7/22 | 3/8/23 | 3/19/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 709.3 | 1,448 | 1,939 | 2,869 | 3,900 | 5,175 | 6,401 |
| EBITDA 1 | 513.7 | 1,137 | 1,504 | 2,195 | 2,824 | 3,670 | 4,505 |
| EBIT 1 | 502.7 | 1,127 | 1,488 | 2,158 | 2,867 | 3,742 | 4,608 |
| Operating Margin | 70.88% | 77.81% | 76.76% | 75.22% | 73.53% | 72.3% | 71.98% |
| Earnings before Tax (EBT) 1 | 502.7 | 1,122 | 1,488 | 2,156 | 2,872 | 3,763 | 4,647 |
| Net income 1 | 439.7 | 957.8 | 1,264 | 1,858 | 2,465 | 3,231 | 3,977 |
| Net margin | 62% | 66.15% | 65.17% | 64.77% | 63.22% | 62.43% | 62.13% |
| EPS 2 | 2.504 | 4.430 | 5.840 | 8.600 | 11.40 | 14.93 | 18.38 |
| Free Cash Flow 1 | - | 919.8 | 1,038 | 1,890 | 2,664 | 3,023 | 3,671 |
| FCF margin | - | 63.52% | 53.55% | 65.88% | 68.31% | 58.42% | 57.35% |
| FCF Conversion (EBITDA) | - | 80.86% | 69.02% | 86.11% | 94.35% | 82.37% | 81.5% |
| FCF Conversion (Net income) | - | 96.03% | 82.17% | 101.72% | 108.05% | 93.58% | 92.31% |
| Dividend per Share 2 | 1.944 | 2.100 | 2.800 | 2.323 | 4.614 | 5.659 | 6.765 |
| Announcement Date | 2/8/21 | 3/7/22 | 3/8/23 | 3/19/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 454.2 | 604.5 | 449.4 | 630.1 | 829.4 | 1,459 | 710.8 | 699 | 808.1 | 1,145 | 981.7 | 965.1 | 1,167 | 1,536 |
| EBITDA 1 | - | 323.7 | - | - | - | - | - | - | - | - | 871.2 | 717 | 581.2 | - | - |
| EBIT 1 | - | 361.4 | 470.3 | 328.4 | 485.3 | - | - | 533.1 | 509.5 | 621.9 | 843.1 | 717 | 581.2 | - | - |
| Operating Margin | - | 79.56% | 77.8% | 73.09% | 77.02% | - | - | 74.99% | 72.88% | 76.96% | 73.63% | 73.04% | 60.22% | - | - |
| Earnings before Tax (EBT) 1 | - | - | - | - | 485.6 | 630 | - | 533.2 | 506.8 | 622.1 | 877.3 | 751 | 599.4 | - | - |
| Net income 1 | 280.1 | - | - | - | 414.1 | 549.3 | 963.4 | 454.9 | 440.2 | 527.4 | 756.4 | 646.7 | 517 | - | - |
| Net margin | - | - | - | - | 65.71% | 66.24% | 66.01% | 64% | 62.97% | 65.27% | 66.06% | 65.88% | 53.58% | - | - |
| EPS 2 | 1.290 | 1.440 | 1.860 | 1.250 | 1.910 | 2.540 | - | 2.100 | 2.050 | 2.450 | 2.880 | 2.920 | 2.940 | 3.360 | 3.560 |
| Dividend per Share 2 | - | - | - | - | - | 1.848 | - | - | - | - | 3.058 | - | - | - | 4.090 |
| Announcement Date | 4/26/22 | 8/24/22 | 10/25/22 | 3/8/23 | 4/25/23 | 8/24/23 | 8/24/23 | 10/24/23 | 3/19/24 | 4/24/24 | - | - | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 3,256 | 3,128 | 2,419 | 4,032 | 6,021 | 8,527 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 920 | 1,038 | 1,890 | 2,664 | 3,023 | 3,671 |
| ROE (net income / shareholders' equity) | 25.3% | 19.1% | 23.7% | 30.1% | 33% | 31.3% | 30.9% |
| ROA (Net income/ Total Assets) | 16.4% | 18.5% | 21.9% | 28.4% | 29.4% | 30.5% | 29.8% |
| Assets 1 | 2,688 | 5,184 | 5,762 | 6,555 | 8,382 | 10,575 | 13,324 |
| Book Value Per Share 2 | 21.00 | 23.20 | 27.00 | 29.30 | 37.40 | 50.40 | 64.40 |
| Cash Flow per Share 2 | 1.970 | 4.360 | 5.520 | 9.030 | 11.20 | 14.50 | 18.30 |
| Capex 1 | 32.1 | 23 | 156 | 63.7 | 85.3 | 91.2 | 107 |
| Capex / Sales | 4.52% | 1.59% | 8.03% | 2.22% | 2.19% | 1.76% | 1.68% |
| Announcement Date | 2/8/21 | 3/7/22 | 3/8/23 | 3/19/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
297
CNY
Average target price
438.1
CNY
Spread / Average Target
+47.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.91% | 8.82B | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B | |
| -22.81% | 1.79B |
- Stock Market
- Equities
- 300896 Stock
- Financials Imeik Technology Development Co.,Ltd.
